A low incidence of grade II to IV acute GVHD, but high mortality from infection using HLA-A, -B, and -DR-identical unrelated donors and immunosuppression with ATG, cyclosporine, and methotrexate

Transplant Proc. 1997 Feb-Mar;29(1-2):735-6. doi: 10.1016/s0041-1345(96)00444-7.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Acute Disease
  • Adult
  • Antilymphocyte Serum / therapeutic use
  • Bone Marrow Transplantation / immunology*
  • Communicable Diseases / mortality*
  • Cyclosporine / therapeutic use
  • Graft vs Host Disease / epidemiology
  • Graft vs Host Disease / prevention & control*
  • HLA-A Antigens
  • HLA-B Antigens
  • HLA-DR Antigens
  • Histocompatibility Testing*
  • Humans
  • Immunosuppression Therapy / methods*
  • Immunosuppressive Agents / therapeutic use*
  • Incidence
  • Leukemia / therapy
  • Living Donors
  • Lymphoma / therapy
  • Metabolism, Inborn Errors / therapy
  • Methotrexate / therapeutic use
  • Multiple Myeloma / therapy
  • Myelodysplastic Syndromes / therapy
  • Nuclear Family

Substances

  • Antilymphocyte Serum
  • HLA-A Antigens
  • HLA-B Antigens
  • HLA-DR Antigens
  • Immunosuppressive Agents
  • Cyclosporine
  • Methotrexate